Evaluation of montelukast in 8 to 14 year old children with mild persistent asthma and compared with inhaled corticosteroids

Allergologia et Immunopathologia

Volumn 32, Issue 1, 2004, Pages 21-27

  Karaman, O ^a   Sunneli L ^a   Uzuner, Nevin ^a,b   Islekel H ^a   Sule Turgut, C ^a   Kose S ^a   Tezcan, D ^a   Coker C ^a   Erbayraktar, Z ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b Vali Huseyin Ogutcen Cad   (Turkey)

Author keywords

Childhood asthma; Montelukast; Urinary leukotriene E4

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE E4; MONTELUKAST;

ADOLESCENT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT OUTCOME; URINE LEVEL; WAKEFULNESS;

EID: 12144288437     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: 10.1157/13057766     Document Type: Article

References (22)

1. Guidelines for the Diagnosis and Management of Asthma. U.S. Department of Health and Human Services, National Instute of Health, Bethesda, MD. National Asthma Education and Prevention Program. Expert Panel Report II. 1997.
2. Cochrane GM. Compliance in asthma. Eur Respir Rev 1995;28:164-5.
3. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. N Engl J Med 1990; 323:645-55.
4. rd ed. Mc Graw-Hill Newyork, 1998; pp. 757-76.
5. Knorr B, Matz J, Bernstein A, et al. Montelukast for chronic asthma in 6-to-14-year old children. JAMA 1998;279:1181-6.
6. 4 receptor antagonist. Can J Physiol Pharmacol 1995;73(2):191-201.
7. 4-receptor antagonism in the airways of patients with asthma. Clin Pharmacol Ther 1995;61(1):83-92.
8. 4 receptor antagonist, inhibits exercise induced bronchoconstriction in astmatics at the end of a once daily dosing interval. Am J Respir Crit Care Med 1995;151:A377.
9. Aas K, Belin L. Standardization of diagnostic work in allergy. Acta Allergologica 1972;27:439-68.
10. Adelroth E, Inman MD, Summers E, et al. Prolenged protection againts exercise-induced bronchoconstriction by the leukotriene D4 receptor antagonist cinalukast. J Allergy Clin Immunol. 1997;99:210-5.
11. 1 receptor antagonist, improves the sign and symptoms of asthma over a 3 month treatment period (abstract). Eur Respir J. 1996;9:273s.
12. Juniper EF, Guyatt GH, Feeny P, et al. Measuring the quality of life in children with asthma. Qual Life Res. 1996;5:35-46.
13. Jeffery PK, Wardlaw AJ, Nelson FC, et al. Bronchial biopsises in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140:1745-53.
14. Wempe JB, Tammeling EP, Koeter GH, et al. Blood eosinophil numbers and activity during 24 hours: effect of treatment with budesonide and bambuterol. J Allergy Clin Immunol 1992; 90:757-65.
15. Fuller R, Johnson M, Bye A. Fluticasone propionate-an update on preclinical and clinical experience. Respir Med 1995;89:3-18.
16. Wickremasingke RG, Kahn MA, Hoffbrand AV. Do leukotrienes play a role in the regulation of proliferation of normal and leukomic hemopoietic cells? Prostoglandins Leukotr Essent Fatty Acids 1993;48:123-6.
17. Pizzichini E, Leff JA, Reiss TF, et al. Montelukast reduces airway eosinophilic inflammation in asthma. Eur Respir J 1999;14:12-8.
18. Laviolette M, Malmstrom K, Lu S, et al. Montelukast Added to inhaled Beclomethasone in Treatment of Asthma. Am J Respir Crit Care Med 1999;160:1862-8.
19. Noonan MJ, Chervinky P, Brandon M, et al. Montelukast, a potent leukotriene receptor antagonist, causes dose related improvements in chronic asthma. Eur Respir J 1998;11(6): 1232-9.
20. 4 from the urine of patients with airway obstruction. Am Rec Respir Dis. 1992;146:104-8.
21. 4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma. J Allergy Clin Immunol 1995;96:643-51.
22. Dworski R, Fitzgerald GA, Oates JA, et al. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994;149:953-9.